Journal
BRAIN RESEARCH
Volume 1706, Issue -, Pages 93-100Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2018.10.032
Keywords
Amyotrophic lateral sclerosis (ALS); Neurofilaments; Pcripherin (PRPH); Alpha-intemexin (INA); microRNAs; mRNA metabolism
Categories
Funding
- European Research Projects on Rare Diseases (E-Rare-2)
- ALS Society of Canada
Ask authors/readers for more resources
Intermediate filament aggregation within motor neurons is a hallmark of ALS pathogenesis. Changes to intermediate filament stoichiometry due to altered mRNA steady-state levels of NEFL, PRPH and INA is thought to drive protein aggregation, yet the exact cause of these changes is unknown. MicroRNAs (miRNAs)-master regulators of gene expression-are largely dysregulated within ALS motor neurons and are known to be major contributors to the disease. We show that miR-105 and miR-9 are down-regulated within the spinal cord of ALS patients and target NEFL, PRPH and INA 3'UTRs to regulate gene expression. Further, both miR-105 and miR-9 were observed to regulate the mRNA stability of these three intermediate filaments endogenously within a neuronal-derived cell line. Our data demonstrates that miR-105 and miR-9 can regulate the mRNA stability of these key intermediate filaments and thus potentially contribute to the pathogenesis of intermediate filament inclusions in ALS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available